69 related articles for article (PubMed ID: 8896493)
1. Epidemiologic determinants of seroreactivity to human papillomavirus (HPV) type 16 virus-like particles in cervical HPV-16 DNA-positive and-negative women.
Wideroff L; Schiffman MH; Hoover R; Tarone RE; Nonnenmacher B; Hubbert N; Kirnbauer R; Greer CE; Lorincz AT; Manos MM; Glass AG; Scott DR; Sherman ME; Buckland J; Lowy D; Schiller J
J Infect Dis; 1996 Nov; 174(5):937-43. PubMed ID: 8896493
[TBL] [Abstract][Full Text] [Related]
2. Correlation between cervical HPV DNA detection and HPV16 seroreactivity measured with L1-only and L1+L2 viral capsid antigens.
Trevisan A; Candeias JMG; Thomann P; Villa LL; Franco EL; Trottier H; The Ludwig-McGill Study Group
J Med Microbiol; 2020 Jul; 69(7):960-970. PubMed ID: 32510304
[No Abstract] [Full Text] [Related]
3. Evaluation of seroreactivity to human papillomavirus type 16 virus-like particles in an incident case-control study of cervical neoplasia.
Wideroff L; Schiffman MH; Nonnenmacher B; Hubbert N; Kirnbauer R; Greer CE; Lowy D; Lorincz AT; Manos MM; Glass AG
J Infect Dis; 1995 Dec; 172(6):1425-30. PubMed ID: 7594698
[TBL] [Abstract][Full Text] [Related]
4. Seroreactivity to human papillomavirus types 16, 18, 31, and 45 virus-like particles in a case-control study of cervical squamous intraepithelial lesions.
Wideroff L; Schiffman M; Haderer P; Armstrong A; Greer CE; Manos MM; Burk RD; Scott DR; Sherman ME; Schiller JT; Hoover RN; Tarone RE; Kirnbauer R
J Infect Dis; 1999 Nov; 180(5):1424-8. PubMed ID: 10515799
[TBL] [Abstract][Full Text] [Related]
5. Seroreactivity to HPV16 virus-like particles as a marker for cervical cancer risk in high-risk populations.
Nonnenmacher B; Kruger Kjaer S; Svare EI; Scott JD; Hubbert NL; van den Brule AJ; Kirnbauer R; Walboomers JM; Lowy DR; Schiller JT
Int J Cancer; 1996 Dec; 68(6):704-9. PubMed ID: 8980170
[TBL] [Abstract][Full Text] [Related]
6. Serologic response to human oncogenic papillomavirus types 16, 18, 31, 33, 39, 58 and 59 virus-like particles in colombian women with invasive cervical cancer.
Combita AL; Bravo MM; Touzé A; Orozco O; Coursaget P
Int J Cancer; 2002 Feb; 97(6):796-803. PubMed ID: 11857357
[TBL] [Abstract][Full Text] [Related]
7. Sexual behavior, human papillomavirus type 16 (HPV 16) infection, and HPV 16 seropositivity.
Castle PE; Shields T; Kirnbauer R; Manos MM; Burk RD; Glass AG; Scott DR; Sherman ME; Schiffman M
Sex Transm Dis; 2002 Mar; 29(3):182-7. PubMed ID: 11875380
[TBL] [Abstract][Full Text] [Related]
8. Serologic response to human papillomavirus type 16 (HPV-16) virus-like particles in HPV-16 DNA-positive invasive cervical cancer and cervical intraepithelial neoplasia grade III patients and controls from Colombia and Spain.
Nonnenmacher B; Hubbert NL; Kirnbauer R; Shah KV; Muñoz N; Bosch FX; de Sanjosé S; Viscidi R; Lowy DR; Schiller JT
J Infect Dis; 1995 Jul; 172(1):19-24. PubMed ID: 7797910
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus DNA in urine samples of women with or without cervical cancer and their male partners compared with simultaneously collected cervical/penile smear or biopsy specimens.
Gupta A; Arora R; Gupta S; Prusty BK; Kailash U; Batra S; Das BC
J Clin Virol; 2006 Nov; 37(3):190-4. PubMed ID: 16931139
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of antibodies to human papillomavirus (HPV) type 16 virus-like particles in relation to cervical HPV infection among college women.
Viscidi RP; Kotloff KL; Clayman B; Russ K; Shapiro S; Shah KV
Clin Diagn Lab Immunol; 1997 Mar; 4(2):122-6. PubMed ID: 9067643
[TBL] [Abstract][Full Text] [Related]
11. The natural history of human papillomavirus type 16 capsid antibodies among a cohort of university women.
Carter JJ; Koutsky LA; Wipf GC; Christensen ND; Lee SK; Kuypers J; Kiviat N; Galloway DA
J Infect Dis; 1996 Nov; 174(5):927-36. PubMed ID: 8896492
[TBL] [Abstract][Full Text] [Related]
12. Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer.
Wallin KL; Wiklund F; Angström T; Bergman F; Stendahl U; Wadell G; Hallmans G; Dillner J
N Engl J Med; 1999 Nov; 341(22):1633-8. PubMed ID: 10572150
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for subsequent cervicovaginal human papillomavirus (HPV) infection and the protective role of antibodies to HPV-16 virus-like particles.
Ho GY; Studentsov Y; Hall CB; Bierman R; Beardsley L; Lempa M; Burk RD
J Infect Dis; 2002 Sep; 186(6):737-42. PubMed ID: 12198606
[TBL] [Abstract][Full Text] [Related]
14. Seroreactivity to human papillomavirus type 16 virus-like particles is lower in high-risk men than in high-risk women.
Svare EI; Kjaer SK; Nonnenmacher B; Worm AM; Moi H; Christensen RB; van den Brule AJ; Walboomers JM; Meijer CJ; Hubbert NL; Lowy DR; Schiller JT
J Infect Dis; 1997 Oct; 176(4):876-83. PubMed ID: 9333144
[TBL] [Abstract][Full Text] [Related]
15. HPV-16-related proteins as the serologic markers in cervical neoplasia.
Park JS; Park DC; Kim CJ; Ahn HK; Um SJ; Park SN; Kim SJ; Namkoong SE
Gynecol Oncol; 1998 Apr; 69(1):47-55. PubMed ID: 9570998
[TBL] [Abstract][Full Text] [Related]
16. Correlation between the presence of anti HPV33 VLP antibodies and HPV DNA in cervical neoplasia patients.
Hamsíková E; Smahel M; Sapp M; Munoz N; Bosch FX; Shah KV; Vonka V
Arch Virol; 1997; 142(2):413-6. PubMed ID: 9125054
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.
Walboomers JM; Jacobs MV; Manos MM; Bosch FX; Kummer JA; Shah KV; Snijders PJ; Peto J; Meijer CJ; Muñoz N
J Pathol; 1999 Sep; 189(1):12-9. PubMed ID: 10451482
[TBL] [Abstract][Full Text] [Related]
18. Serum immunoglobulin A response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women.
Viscidi RP; Ahdieh-Grant L; Schneider MF; Clayman B; Massad LS; Anastos KM; Burk RD; Minkoff H; Palefsky J; Levine A; Strickler H
J Infect Dis; 2003 Dec; 188(12):1834-44. PubMed ID: 14673762
[TBL] [Abstract][Full Text] [Related]
19. A population-based study of vaginal human papillomavirus infection in hysterectomized women.
Castle PE; Schiffman M; Bratti MC; Hildesheim A; Herrero R; Hutchinson ML; Rodriguez AC; Wacholder S; Sherman ME; Kendall H; Viscidi RP; Jeronimo J; Schussler JE; Burk RD
J Infect Dis; 2004 Aug; 190(3):458-67. PubMed ID: 15243917
[TBL] [Abstract][Full Text] [Related]
20. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia.
Schiffman MH; Bauer HM; Hoover RN; Glass AG; Cadell DM; Rush BB; Scott DR; Sherman ME; Kurman RJ; Wacholder S
J Natl Cancer Inst; 1993 Jun; 85(12):958-64. PubMed ID: 8388478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
